P-glycoprotein-Inhibitors-Modulators-MCE.docx 免费下载
版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、 HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html P-glycoproteinP-gp; Pgp; Multidrug resistance protein 1; MDR1; ATP-binding cassette sub-family B member 1; ABCB1;Cluster of differentiation 243; CD243P-glycoprotein (P-gp) also known as multidrug resistance protein 1 (MDR1) is an important p
2、rotein of the cell membrane thatpumps many foreign substances out of cells. More formally, it is an ATP-dependent efflux pump with broad substrate specificity.P-gp is extensively distributed and expressed in the intestinal epithelium where it pumps xenobiotics (such as toxins or drugs) backinto the
3、intestinal lumen, in liver cells where it pumps them into bile ducts, in the cells of the proximal tubular of the kidney where itpumps them into urine-conducting ducts, and in the capillary endothelial cells comprising the bloodbrain barrier and blood-testisbarrier, where it pumps them back into the
4、 capillaries. Some cancer cells also express large amounts of P-gp, which renders thesecancers multi-drug resistant. P-gp is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substratespecificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and
5、often mediates the development ofresistance to anticancer drugs. This protein also functions as a transporter in the bloodbrain barrier.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html P-glycoprotein HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html HYPERLINK https:/w
6、ww.MedChemE/Targets/P-glycoprotein.html Inhibitors, HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html Agonists, HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html Activa
7、tors HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html & HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html HYPERLINK https:/www.MedChemE/Targets/P-glycoprotein.html Modulators HYPERLINK https:/www.MedChemE/_20S_-Protopanaxadio
8、l.html (20S)-Protopanaxadiol(20-Epiprotopanaxadiol; 20(S)-APPD) Cat. No.: HY-N0797 HYPERLINK https:/www.MedChemE/r-verapamil-d7-hydrochloride.html (R)-Verapamil HYPERLINK https:/www.MedChemE/r-verapamil-d7-hydrochloride.html HYPERLINK https:/www.MedChemE/r-verapamil-d7-hydrochloride.html D7 HYPERLIN
9、K https:/www.MedChemE/r-verapamil-d7-hydrochloride.html HYPERLINK https:/www.MedChemE/r-verapamil-d7-hydrochloride.html hydrochloride(R)-(+)-Verapamil D7 hydrochloride) Cat. No.: HY-135336S20S-protopanaxadiol (aPPD) is a metabolite ofginseng saponins, inhibits Akt activity andinduces apoptosis in va
10、rious tumor cells.(R)-Verapamil D7 hydrochloride (R)-(+)-VerapamilD7 hydrochloride) is a deuterium labeled(R)-Verapamil hydrochloride. (R)-Verapamilhydrochloride (R)-(+)-Verapamil hydrochloride) isa P-Glycoprotein inhibitor.Purity: 98.0%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 10 mg,
11、50 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg HYPERLINK https:/www.MedChemE/r-verapamil-hydrochloride.html (R)-Verapamil HYPERLINK https:/www.MedChemE/r-verapamil-hydrochloride.html HYPERLINK https:/www.MedChemE/r-verapamil-hydrochloride.html hydrochloride(R)-(+)-Verapamil hydroch
12、loride) Cat. No.: HY-135336 HYPERLINK https:/www.MedChemE/atazanavir.html Atazanavir(BMS-232632) Cat. No.: HY-17367(R)-Verapamil hydrochloride (R)-(+)-Verapamilhydrochloride) is a P-Glycoprotein inhibitor.(R)-Verapamil hydrochloride blocks MRP1 mediatedtransport, resulting in chemosensitization ofMR
13、P1-overexpressing cells to anticancer drugs.Atazanavir (BMS-232632), a highly selective HIV-1protease inhibitor, is the first proteaseinhibitor approved for once-daily administration.Atazanavir (BMS-232632) is a substrate andinhibitor of CYP3A4, and an inhibitor and inducerof P-glycoprotein (P-gp).P
14、urity: 98.54%Clinical Data: LaunchedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: LaunchedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Atazanavir-sulfate.html Atazanavir HYPERLINK https:/www.MedChemE/Atazanavir-sulfate.html HYPERLINK https:/www.MedChemE/Atazanavir-sulfate.h
15、tml sulfate(BMS-232632 sulfate) Cat. No.: HY-17367A HYPERLINK https:/www.MedChemE/atazanavir-d5.html Atazanavir-d5Cat. No.: HY-17367S3Atazanavir (BMS-232632) sulfate, a highlyselective HIV-1 protease inhibitor, is the firstprotease inhibitor approved for once-dailyadministration. Atazanavir sulfate
16、is a substrateand inhibitor of CYP3A4, and an inhibitor andinducer of P-glycoprotein (P-gp).Atazanavir-d5 is the deuterium labeled Atazanavir.Atazanavir (BMS-232632), a highly selective HIV-1protease inhibitor, is the first proteaseinhibitor approved for once-daily administration.Purity: 99.94%Clini
17、cal Data: LaunchedSize: 10 mM 1 mL, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 10 mg HYPERLINK https:/www.MedChemE/atazanavir-d6.html Atazanavir-d6 HYPERLINK https:/www.MedChemE/atazanavir-d6.html HYPERLINK https:/www.MedChemE/atazanavir-d9.html Atazanavir-d9(BM
18、S-232632-d6) Cat. No.: HY-17367S4 (BMS-232632-d9) Cat. No.: HY-17367S2Atazanavir-d6 is deuterium labeled Atazanavir.Atazanavir (BMS-232632), a highly selective HIV-1protease inhibitor, is the first proteaseinhibitor approved for once-daily administration.Atazanavir-d9 (BMS-232632-d9) is the deuteriu
19、mlabeled Atazanavir. Atazanavir (BMS-232632), ahighly selective HIV-1 protease inhibitor, is thefirst protease inhibitor approved for once-dailyadministration.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg HYP
20、ERLINK https:/www.MedChemE/azd-5672.html AZD-5672 HYPERLINK https:/www.MedChemE/azd-5672.html HYPERLINK https:/www.MedChemE/Biricodar.html BiricodarCat. No.: HY-119101(VX-710) Cat. No.: HY-13574AAZD-5672 is an orally active, potent, andselective CCR5 antagonist (IC =0.32 nM).50AZD-5672 shows moderat
21、e activity against the hERGion channel (binding IC =7.3 M).50Biricodar (VX-710) is a modulator of P-glycoproteinand MRP-1; shows effective chemosensitizingactivity in multidrug resistant cells.Purity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 98%Clinical
22、 Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/boeravinone-b.html Boeravinone HYPERLINK https:/www.MedChemE/boeravinone-b.html HYPERLINK https:/www.MedChemE/boeravinone-b.html B HYPERLINK https:/www.MedChemE/boer
23、avinone-b.html HYPERLINK https:/www.MedChemE/chrysosplenetin.html ChrysosplenetinCat. No.: HY-N2947 Cat. No.: HY-N1457Boeravinone B, a dual inhibitor of NorA bacterialefflux pump of Staphylococcus aureus and humanP-Glycoprotein, reduces the biofilm formation andintracellular invasion of bacteria. Bo
24、eravinone Bact as anti-aging and anti-apoptosisphyto-molecules during oxidative stress.Chrysosplenetin is one of the polymethoxylatedflavonoids in Artemisia annua L. (Compositae)and other several Chinese herbs. Chrysosplenetininhibits P-gp activity and reverses theup-regulated P-gp and MDR1 levels i
25、nduced byartemisinin (ART).Purity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mgPurity: 99.52%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 20 mg HYPERLINK https:/www.MedChemE/coniferyl-ferulate.html Coniferyl HYPERLINK https:/www.MedChemE/coniferyl-ferulate.html HYPER
26、LINK https:/www.MedChemE/coniferyl-ferulate.html ferulate HYPERLINK https:/www.MedChemE/coniferyl-ferulate.html HYPERLINK https:/www.MedChemE/convallatoxin.html ConvallatoxinCat. No.: HY-N1916 Cat. No.: HY-N2453Coniferyl ferulate, a strong inhibitor ofglutathione S-transferase (GST), reversesmultidr
27、ug resistance and downregulatesP-glycoprotein. Coniferyl ferulate shows stronginhibition of human placental GST with an IC of500.3M.Convallatoxin is a cardiac glycoside isolated fromAdonis amurensis Regel et Radde. Convallatoxinameliorates colitic inflammation via activation ofPPAR and suppression o
28、f NF-B.Purity: 98.56%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mgPurity: 98.66%Clinical Data: No Development ReportedSize: 5 mg, 25 mg, 50 mg HYPERLINK https:/www.MedChemE/cp-100356-hydrochloride.html CP-100356 HYPERLINK https:/www.MedChemE/cp-100356-hydrochloride.html HYPERLINK htt
29、ps:/www.MedChemE/cp-100356-hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/cp-100356-hydrochloride.html HYPERLINK https:/www.MedChemE/Dofequidar.html DofequidarCat. No.: HY-108347 Cat. No.: HY-17013CP-100356 hydrochloride is an orally active dualMDR1 (P-gp)/BCRP inhibitor, with an IC
30、s of500.5 and 1.5 M for inhibiting MDR1-mediatedCalcein-AM transport and BCRP-mediated Prazosintransport, respectively.Dofequidar(MS-209) is a novel quinoline compound,which can reverse P-glycoprotein (P-gp)-mediatedMDR.Purity: 99.68%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50
31、 mgPurity: 98%Clinical Data: Phase 1Size: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/Dofequidar-fumarate.html Dofequidar HYPERLINK https:/www.MedChemE/Dofequidar-fumarate.html HYPERLINK https:/www.MedChemE/Dofequidar-fumarate.html fumarate HYPERLINK https:/www.MedChemE/Dofequidar-fumarate.html HYPERLI
32、NK https:/www.MedChemE/elacridar.html Elacridar(MS-209) Cat. No.: HY-17013A (GF120918; GW0918; GG918; GW120918) Cat. No.: HY-50879Dofequidar fumarate(MS-209 fumarate), an orallyactive quinoline compound, has been reported toovercome MDR by inhibiting ABCB1/P-gp,ABCC1/MDR-associated protein 1, or bot
33、h.Elacridar (GF120918) is a potent P-glycoprotein(Pgp) and BCRP inhibitor.Purity: 98.40%Clinical Data: Phase 1Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.80%Clinical Data: No Development ReportedSize: 10 mg, 50 mg, 100 mg, 200 mg, 500 mg HYPERLINK https:/www.MedChemE/elacridar-hydrochlori
34、de.html Elacridar HYPERLINK https:/www.MedChemE/elacridar-hydrochloride.html HYPERLINK https:/www.MedChemE/elacridar-hydrochloride.html hydrochloride HYPERLINK https:/www.MedChemE/elacridar-hydrochloride.html HYPERLINK https:/www.MedChemE/HM30181.html Encequidar(GF120918A) Cat. No.: HY-50880 (HM3018
35、1; HM30181A) Cat. No.: HY-13646Elacridar hydrochloride (GF120918A) is a potentP-glycoprotein (Pgp) and BCRP inhibitor.Encequidar (HM30181; HM30181A) is a potent andselective inhibitor of P-glycoprotein.Purity: 99.73%Clinical Data: No Development ReportedSize: 10 mg, 50 mg, 100 mgPurity: 98.0%Clinica
36、l Data: Phase 2Size: 5 mg, 10 mg, 50 mg, 100 mgwww.MedChemE 3 HYPERLINK https:/www.MedChemE/HM30181_mesylate.html Encequidar HYPERLINK https:/www.MedChemE/HM30181_mesylate.html HYPERLINK https:/www.MedChemE/HM30181_mesylate.html mesylate(HM30181 mesylate; HM30181A mesylate) Cat. No.: HY-13646A HYPER
37、LINK https:/www.MedChemE/epoxylathyrol.html EpoxylathyrolCat. No.: HY-N0425Encequidar mesylate (HM30181 mesylate; HM30181Amesylate) is a competitive and potentP-glycoprotein inhibitor.Epoxylathyrol, an epoxylathyrane derivativeisolated from the Euphorbia boetica, is aP-glycoprotein (P-gp) inhibitor.
38、 Epoxylathyrol isa P-gp-mediated multidrug resistance (MDR)reverser.Purity: 99.90%Clinical Data: Phase 1Size: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg HYPERLINK https:/www.MedChemE/evodine.html EvodineCat. No.: HY-N0689 HYPERLINK
39、 https:/www.MedChemE/fd-12-9.html FD HYPERLINK https:/www.MedChemE/fd-12-9.html HYPERLINK https:/www.MedChemE/fd-12-9.html 12-9(Ac12Az9) Cat. No.: HY-128685Evodine, the major limonoid of Evodiae Fuctus, isa potent P-gp inhibitor. Evodine has protectionagainst glutamateinduced toxicity by preservingt
40、he antioxidant defense system.FD 12-9 is a flavonoid dimer, acts as a dualinhibitor of P-gp and BCRP, with EC s of 28550nM and 0.9 nM, respectively. Anti-glioblastomaactivity.Purity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mgPurity: 98%Clinical Data: No Development ReportedSiz
41、e: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/furanodiene.html FuranodieneCat. No.: HY-126940 HYPERLINK https:/www.MedChemE/glibenclamide.html Glibenclamide(Glyburide) Cat. No.: HY-15206Furanodiene is a natural terpenoid isolated fromRhizoma Curcumae. Furanodiene playsanti-cancer effects through anti-
42、angiogenesis andinducing ROS production, DNA strand breaks andapoptosis.Glibenclamide (Glyburide) is an orally activeATP-sensitive K+ channel (K ) inhibitor andATPcan be used for the research of diabetes andobesity. Glibenclamide inhibits P-glycoprotein.Purity: 98%Clinical Data: No Development Repor
43、tedSize: 5 mg, 10 mg, 25 mgPurity: 99.79%Clinical Data: LaunchedSize: 10 mM 1 mL, 500 mg, 1 g, 5 g HYPERLINK https:/www.MedChemE/glyburide-d11.html Glyburide-d11 HYPERLINK https:/www.MedChemE/glyburide-d11.html HYPERLINK https:/www.MedChemE/glyburide-d3.html Glyburide-d3Cat. No.: HY-15206S(Glyburide
44、-d3) Cat. No.: HY-15206S1Glyburide-d11 is the deuterium labeledGlibenclamide. Glibenclamide (Glyburide) is anorally active ATP-sensitive K+ channel (K )ATPinhibitor and can be used for the research ofdiabetes and obesity. Glibenclamide inhibitsP-glycoprotein.Glyburide-d3 (Glyburide-d3) is the deuter
45、iumlabeled Glibenclamide. Glibenclamide (Glyburide)is an orally active ATP-sensitive K+ channel(K ) inhibitor and can be used for theATPresearch of diabetes and obesity. Glibenclamideinhibits P-glycoprotein.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 10 mgPurity: 98%Clinical Data: N
46、o Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/htt-d3.html HTT-D3 HYPERLINK https:/www.MedChemE/htt-d3.html HYPERLINK https:/www.MedChemE/hypophyllanthin.html HypophyllanthinCat. No.: HY-143792 Cat. No.: HY-N4108HTT-D3 is a potent and orally active huntingtin(HTT) splicing modu
47、lator. HTT-D3 acts bypromoting the inclusion of a pseudoexon containinga premature termination codon (stop-codonpsiExon), leading to HTT mRNA degradation andreduction of HTT levels.Hypophyllanthin is a major lignan in Phyllanthusspp, with strong anti-inflammatory activity.Hypophyllanthin directly in
48、hibits P-glycoprotein(P-gp) activity and did not interfere withmultidrug resistance protein 2 (MRP2) activity.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.40%Clinical Data: No Development ReportedSize: 1 mg, 5 mg4 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChem
49、E HYPERLINK https:/www.MedChemE/isosinensetin.html IsosinensetinCat. No.: HY-N1941 HYPERLINK https:/www.MedChemE/laniquidar.html Laniquidar(R101933) Cat. No.: HY-132189Isosinensetin, a polymethoxylated flavoneextracted from pericarpium citri reticulataeviride, exhibits inhibition on P-glycoprotein(P
50、-gp) in MDR1-MDCKII cells.Laniquidar (R101933) is a noncompetitive, thirdgeneration P-glycoprotein (P-gp) inhibitor with anIC of 0.51 M. Laniquidar can be used for50modulating multidrug resistance transporters.Purity: 99.26%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 20 mgPurity: 98%Cli
51、nical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/mc70.html MC70 HYPERLINK https:/www.MedChemE/mc70.html HYPERLINK https:/www.MedChemE/MCI826.html MCI826Cat. No.: HY-113805 Cat. No.: HY-U00247MC70 is a potent and non-selective P-glycoprotein(P-gp) inhibitor with an EC
52、 of 0.69 M. MC7050is an ABC transporters inhibitor and anticanceragent. MC70 interacts with ABCB1, ABCG2 and ABCC1.MCI826 is a P-glycoprotein (P-gp) antagonist.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK
53、 https:/www.MedChemE/norverapamil.html Norverapamil()-Norverapamil; D591) Cat. No.: HY-135328 HYPERLINK https:/www.MedChemE/Norverapamil-hydrochloride.html Norverapamil HYPERLINK https:/www.MedChemE/Norverapamil-hydrochloride.html HYPERLINK https:/www.MedChemE/Norverapamil-hydrochloride.html hydroch
54、loride()-Norverapamil hydrochloride; D591 hydrochloride) Cat. No.: HY-100750Norverapamil ()-Norverapamil), an N-demethylatedmetabolite of Verapamil, is a L-type calciumchannel blocker and a P-glycoprotein (P-gp)function inhibitor.Norverapamil hydrochloride ()-Norverapamilhydrochloride), an N-demethy
55、lated metabolite ofVerapamil, is a L-type calcium channel blocker anda P-glycoprotein (P-gp) function inhibitor.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98.26%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 2 mg, 5 mg, 10 mg, 25 mg HYPERLINK https:/www.MedChem
56、E/norverapamil-d7.html Norverapamil-d7 HYPERLINK https:/www.MedChemE/norverapamil-d7.html HYPERLINK https:/www.MedChemE/NSC23925.html NSC23925()-Norverapamil-d7; D591-d7) Cat. No.: HY-135328SCat. No.: HY-19626Norverapamil-d7 ()-Norverapamil-d7) is adeuterium labeled Norverapamil ()-Norverapamil).Nor
57、verapamil, an N-demethylated metabolite ofVerapamil, is a L-type calcium channel blocker anda P-glycoprotein (P-gp) function inhibitor.NSC23925 is a novel, selective and effectiveP-glycoprotein (Pgp) inhibitor.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.48%Clinical Da
58、ta: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg HYPERLINK https:/www.MedChemE/ont-093.html ONT-093 HYPERLINK https:/www.MedChemE/ont-093.html HYPERLINK https:/www.MedChemE/P-gp_inhibitor_1.html P-gp HYPERLINK https:/www.MedChemE/P-gp_inhibitor_1.html HYPERLINK https:/www.MedChemE/P-g
59、p_inhibitor_1.html inhibitor HYPERLINK https:/www.MedChemE/P-gp_inhibitor_1.html HYPERLINK https:/www.MedChemE/P-gp_inhibitor_1.html 1(OC 144-093; OC 144093) Cat. No.: HY-15134Cat. No.: HY-101791ONT-093 is a potent inhibitor of P-glycoproteinpump. ONT-093 has the potential for theresearch cancer dis
60、eases.P-gp inhibitor 1 is a novel inhibitor reversingP-glycoprotein-mediated multidrug resistance.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 5 HYPERLINK https:/www.MedChemE/p-gp-inhibitor-2.html P-gp
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025上海劳务派遣合同
- 2025年财务年终总结报告个人工作总结5篇
- (2025)消毒供应中心理论试题(附含答案)
- 银行转让协议合同范本
- 工伤陪偿协议书
- 养鱼用工协议书
- 2025年餐饮业简易劳动合同范本
- 食堂劳务协议书
- 协议书栈互通
- 领养协议书警犬
- 高考语文文学类文本阅读-《雪(-苏康斯坦丁-帕乌斯托夫斯基)》-详细解读课件
- 原创《金属材料各种组织金相图片》教学资料课件
- 个人学习-1 .华美企业文化培训
- 重塑商业模式创新打造企业核心竞争力课件
- 芳香疗法医学知识培训课件
- 2022年宝信软件发展现状及竞争优势分析
- 高级工电工题库:501-600
- 《聚合物基复合材料成型工艺》PPT课件(完整版)
- 初级爆破工程技术人员考试填空题
- 某创业公司员工的自我修养PPT课件
- 《诗经_魏风_伐檀》
评论
0/150
提交评论